In postmenopausal women who were randomly assigned anastrozole, bone mineral density showed significant improvement at the lumbar spine.
Investigators assessed the effect of exercise modality during dietary-induced on bone health.
Romosozumab increased spine and hip bone mineral density after 12 months of treatment.
Romosozumab increased bone mineral density in postmenopausal women through increased bone formation and decreased bone resorption.
Endocrinology Advisor Articles
- Heritability of BMI Stronger in Obesogenic Environments
- Adverse Events Associated With Diazoxide Treatment for Congenital Hyperinsulinism
- Maternal Gluten Intake Associated With Risk for Type 1 Diabetes in Offspring
- Patterns of Evidence-Based Diabetes Interventions at Local Health Departments
- Bone-Derived Factors in the Treatment of Diabetes
- Vitamin D Supplementation Has No Effect on Musculoskeletal Health
- Deep Learning Algorithm Efficiently Detects Vision-Threatening Diabetic Retinopathy
- Industry-Funded Trials Often Involve Employees in Studies
- Nutrition Tips for Physicians: Staying Healthy During Busy Days
- Early-Onset Asthma/Wheezing Associated With Later Childhood Obesity